We evaluated SGLT1 expression in patients with DCM, examined the effect of SGLT1 inhibition on the development of DCM, and investigated whether SGLT1 works through the JNK and p38 pathway. The gene discussed is MAPK8; the disease is familial dilated cardiomyopathy.